Ignite Creation Date:
2025-12-24 @ 5:43 PM
Ignite Modification Date:
2026-01-02 @ 3:49 AM
Study NCT ID:
NCT04182568
Status:
UNKNOWN
Last Update Posted:
2019-12-02
First Post:
2019-11-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Nab-paclitaxel Compared With Docetaxel Followed by Anthracyclines and Cyclophosphamide in the Neoadjuvant Breast Cancer
Sponsor:
Xijing Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-08-21
Start Date Type:
ACTUAL
Primary Completion Date:
2021-08-21
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-08-21
Completion Date Type:
ESTIMATED
First Submit Date:
2019-11-27
First Submit QC Date:
None
Study First Post Date:
2019-12-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-11-27
Last Update Post Date:
2019-12-02
Last Update Post Date Type:
ACTUAL